Sex differences in metabolic aging of the brain: Insights into female susceptibility to Alzheimer's disease

Neurobiology of Aging

Volumn 42, Issue , 2016, Pages 69-79

  Zhao, Liqin ^a,b,c   Mao, Zisu ^c   Woody, Sarah K ^a   Brinton, Roberta D ^c,d  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid metabolism; Energy metabolism; Metabolic aging; Prevention; Risk reduction; Sex differences

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN METABOLISM; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; ENERGY METABOLISM; ENERGY YIELD; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; PROTEIN METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; RNA ISOLATION; SEX DIFFERENCE; ANIMAL; BRAIN; C57BL MOUSE; GENETICS; HUMAN; METABOLISM; RISK; SEXUAL DEVELOPMENT;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE SUSCEPTIBILITY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MICE, INBRED C57BL; RISK; SEX CHARACTERISTICS;

EID: 84963706215     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.02.011     Document Type: Article

References (59)

1. Altmann A., Tian L., Henderson V.W., Greicius M.D. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann. Neurol. 2014, 75:563-573.
2. Alzheimer's Association, 2015. Women with Mild Cognitive Impairment Decline Twice as Fast as Men with the Condition. Available at: Accessed August 10, 2015. http://www.alz.org.
3. Alzheimer's Society, 2015. The progression of Alzheimer's disease and other dementias. Available at: Accessed April 2, 2015. http://www.alzheimers.org.uk.
4. Artero S., Ancelin M.L., Portet F., Dupuy A., Berr C., Dartigues J.F., Tzourio C., Rouaud O., Poncet M., Pasquier F., Auriacombe S., Touchon J., Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J. Neurol. Neurosurg. Psychiatry 2008, 79:979-984.
5. Barnes L.L., Wilson R.S., Bienias J.L., Schneider J.A., Evans D.A., Bennett D.A. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch. Gen. Psychiatry 2005, 62:685-691.
6. Bassil F., Fernagut P.O., Bezard E., Meissner W.G. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?. Prog. Neurobiol. 2014, 118:1-18.
7. Benarroch E.E. Insulin-like growth factors in the brain and their potential clinical implications. Neurology 2012, 79:2148-2153.
8. Berti V., Mosconi L., Glodzik L., Li Y., Murray J., De Santi S., Pupi A., Tsui W., De Leon M.J. Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol. Aging 2011, 32:2325.e17-2325.e26.
9. Bertram L., Tanzi R.E. Alzheimer disease: new light on an old CLU. Nat. Rev. Neurol. 2010, 6:11-13.
10. Bretsky P.M., Buckwalter J.G., Seeman T.E., Miller C.A., Poirier J., Schellenberg G.D., Finch C.E., Henderson V.W. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1999, 13:216-221.
11. Brinton R.D. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol. Sci. 2009, 30:212-222.
12. Brookmeyer R., Evans D.A., Hebert L., Langa K.M., Heeringa S.G., Plassman B.L., Kukull W.A. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement 2011, 7:61-73.
13. Carter C.L., Resnick E.M., Mallampalli M., Kalbarczyk A. Sex and gender differences in Alzheimer's disease: recommendations for future research. J. Womens Health (Larchmt) 2012, 21:1018-1023.
14. Chapman R.M., Mapstone M., Gardner M.N., Sandoval T.C., McCrary J.W., Guillily M.D., Reilly L.A., Degrush E. Women have farther to fall: gender differences between Normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J. Int. Neuropsychol. Soc. 2011, 17:654-662.
15. Charnay Y., Imhof A., Vallet P.G., Kovari E., Bouras C., Giannakopoulos P. Clusterin in neurological disorders: molecular perspectives and clinical relevance. Brain Res. Bull 2012, 88:434-443.
16. Daimon M., Oizumi T., Karasawa S., Kaino W., Takase K., Tada K., Jimbu Y., Wada K., Kameda W., Susa S., Muramatsu M., Kubota I., Kawata S., Kato T. Association of the clusterin gene polymorphisms with type 2 diabetes mellitus. Metabolism 2011, 60:815-822.
17. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
18. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationship between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 1998, 55:809-815.
19. Gosden R.G., Laing S.C., Flurkey K., Finch C.E. Graafian follicle growth and replacement in anovulatory ovaries of ageing C57BL/6J mice. J. Reprod. Fertil. 1983, 69:453-462.
20. Hall J.R., Vo H.T., Johnson L.A., Wiechmann A., O'Bryant S.E. Bonston naming test: gender differences in older adults with and without Alzheimer's dementia. Psychology 2012, 3:485-488.
21. Hamilton J. Women's Brains Appear More Vulnerable to Alzheimer's than Men's 2015, Available at:, Accessed August 10, 2015. http://www.npr.org.
22. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., Heun R., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
23. Honea R.A., Swerdlow R.H., Vidoni E.D., Burns J.M. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 2011, 76:822-829.
24. Irvine K., Laws K.R., Gale T.M., Kondel T.K. Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J. Clin. Exp. Neuropsychol. 2012, 34:989-998.
25. Johnson J.K., McCleary R., Oshita M.H., Cotman C.W. Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. Brain Res. 1998, 798:18-24.
26. Kim G., Kim G.H., Oh G.S., Yoon J., Kim H.W., Kim M.S., Kim S.W. SREBP-1c regulates glucose-stimulated hepatic clusterin expression. Biochem. Biophys. Res. Commun. 2011, 408:720-725.
27. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fievet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
28. Livak K.J., Schmittgen T.D. Analyzing real-time PCR data using the comparative Ct method. Nat. Protoc. 2008, 3:1101-1108.
29. McBride R. Pharma Counts Just 3 Alzheimer's Drug Wins in 13 Years (101 Losses). Available at: Accessed September 14, 2012. http://wwwfiercebiotechcom/story/pharma-counts-just-3-alzheimers-drug-wins-13-years-101-losses/2012-09-14.
30. McRory J.E., Sherwood N.M. Ancient divergence of insulin and insulin-like growth factor. DNA Cell Biol. 1997, 16:939-949.
31. Mortensen E.L., Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001, 57:89-95.
32. Mosconi L., Sorbi S., de Leon M.J., Li Y., Nacmias B., Myoung P.S., Tsui W., Ginestroni A., Bessi V., Fayyazz M., Caffarra P., Pupi A. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J. Nucl. Med. 2006, 47:1778-1786.
33. Mosconi L., Berti V., Swerdlow R.H., Pupi A., Duara R., de Leon M. Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum. Genomics 2010, 4:170-193.
34. Mullard A. Sting of Alzheimer's failures offset by upcoming prevention trials. Nat. Rev. Drug Discov. 2012, 11:657-660.
35. Nelson J.F., Felicio L.S., Osterburg H.H., Finch C.E. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol. Reprod. 1981, 24:784-794.
36. Nuutinen T., Suuronen T., Kauppinen A., Salminen A. Clusterin: a forgotten player in Alzheimer's disease. Brain Res. Rev. 2009, 61:89-104.
37. Payami H., Zareparsi S., Montee K.R., Sexton G.J., Kaye J.A., Bird T.D., Yu C.E., Wijsman E.M., Heston L.L., Litt M., Schellenberg G.D. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet. 1996, 58:803-811.
38. Regitz-Zagrosek V., Seeland U. Sex and gender differences in clinical medicine. Handb. Exp. Pharmacol. 2012, 3-22.
39. Rice S. As Drug Trials Fail, Alzheimer's Researchers Look toward Prevention. Available at: Accessed January 25, 2014. http://wwwmodernhealthcarecom/article/20140125/MAGAZINE/301259969#.
40. Rizzi F., Bettuzzi S. The clusterin paradigm in prostate and breast carcinogenesis. Endocr. Relat. Cancer 2010, 17:R1-R17.
41. Sala A., Bettuzzi S., Pucci S., Chayka O., Dews M., Thomas-Tikhonenko A. Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv. Cancer Res. 2009, 105:115-132.
42. Schmidt R., Kienbacher E., Benke T., Dal-Bianco P., Delazer M., Ladurner G., Jellinger K., Marksteiner J., Ransmayr G., Schmidt H., Stogmann E., Friedrich J., Wehringer C. [Sex differences in Alzheimer's disease]. Neuropsychiatr. 2008, 22:1-15.
43. Schnabel J. Why Do All the Large Alzheimer's Drug Trials Fail?. Available at: Accessed July 8, 2013. http://wwwdanaorg/News/Why_Do_All_the_Large_Alzheimer_s_Drug_Trials_Fail_/.
44. Statista, 2015. Average life expectancy at birth in 2014 by continent (in years). Available at: Accessed July 5, 2015. http://www.statista.com.
45. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta 2013, 1842:1219-1231.
46. Thies W., Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 2013, 9:208-245.
47. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 2010, 70:384-396.
48. Trougakos I.P. The molecular chaperone apolipoprotein J/Clusterin as a sensor of oxidative stress: implications in therapeutic approaches-a mini-review. Gerontology 2013, 59:514-523.
49. Ungar L., Altmann A., Greicius M.D. Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imag. Behav. 2014, 8:262-273.
50. Vargas T., Martinez-Garcia A., Antequera D., Vilella E., Clarimon J., Mateo I., Sanchez-Juan P., Rodriguez-Rodriguez E., Frank A., Rosich-Estrago M., Lleo A., Molina-Porcel L., Blesa R., Gomez-Isla T., Combarros O., Bermejo-Pareja F., Valdivieso F., Bullido M.J., Carro E. IGF-I gene variability is associated with an increased risk for AD. Neurobiol. Aging 2011, 32:556.e3-556.e11.
51. Wang W., Yu J.T., Tan L., Liu Q.Y., Wang H.F., Ma X.Y. Insulin-like growth factor 1 (IGF1) polymorphism is associated with Alzheimer's disease in Han Chinese. Neurosci. Lett. 2012, 531:20-23.
52. Wit J.M., Walenkamp M.J. Role of insulin-like growth factors in growth, development and feeding. World Rev. Nutr. Diet. 2013, 106:60-65.
53. Xu X., Zhan M., Duan W., Prabhu V., Brenneman R., Wood W., Firman J., Li H., Zhang P., Ibe C., Zonderman A.B., Longo D.L., Poosala S., Becker K.G., Mattson M.P. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biol. 2007, 8:R234.
54. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14670-14675.
55. Yin F., Jiang T., Cadenas E. Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling. Biochem. Soc. Trans. 2013, 41:101-105.
56. Yu J.T., Tan L. The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy. Mol. Neurobiol. 2012, 45:314-326.
57. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002, 288:2123-2129.
58. Zhao L., Mao Z., Brinton R.D. A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology 2009, 150:770-783.
59. Zhao L., Morgan T.E., Mao Z., Lin S., Cadenas E., Finch C.E., Pike C.J., Mack W.J., Brinton R.D. Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles. PLoS One 2012, 7:e31267.